[Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
Scheffler
P
P
Birkel
L
L
Grub
K R
KR
de la Hamette
D
D
D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001783:Blood Flow Velocity / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005263:Femoral Artery / Q000187:drug effects; D006801:Humans; D007090:Image Interpretation, Computer-Assisted / Q000295:instrumentation; D007262:Infusions, Intravenous; D007511:Ischemia / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D014463:Ultrasonography / Q000295:instrumentation
D000527:Alprostadil
Intravenöse Applikation von PGE1: Untersuchungen zur Wirksamkeit und Wirkdauer verschiedener Dosierungen anhand von Flussmessungen der Arteria femoralis bei Gefässgesunden und AVK IIb.